The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medications for Dry Eye Syndrome Market Research Report 2025
Synopsis
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
In this report, we mainly study the drugs and eye drops for dry eye.
Global Medications for Dry Eye Syndrome market is projected to reach US$ 6838.6 million in 2029, increasing from US$ 5385 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medications for Dry Eye Syndrome market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medications for Dry Eye Syndrome market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bausch & Lomb
URSAPHARM Arzneimittel GmbH
Alcon Inc.
Bayer Inc.
Allergan
SCOPE
Johnson & Johnson Consumer Inc
Novartis Pharmaceuticals Corporation
Segment by Type
Eye Drops
Gels
Ointments
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medications for Dry Eye Syndrome report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
In this report, we mainly study the drugs and eye drops for dry eye.
Global Medications for Dry Eye Syndrome market is projected to reach US$ 6838.6 million in 2029, increasing from US$ 5385 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medications for Dry Eye Syndrome market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medications for Dry Eye Syndrome market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bausch & Lomb
URSAPHARM Arzneimittel GmbH
Alcon Inc.
Bayer Inc.
Allergan
SCOPE
Johnson & Johnson Consumer Inc
Novartis Pharmaceuticals Corporation
Segment by Type
Eye Drops
Gels
Ointments
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medications for Dry Eye Syndrome report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Medications for Dry Eye Syndrome Market Overview
1.1 Product Overview and Scope of Medications for Dry Eye Syndrome
1.2 Medications for Dry Eye Syndrome Segment by Type
1.2.1 Global Medications for Dry Eye Syndrome Market Value Comparison by Type (2023-2029)
1.2.2 Eye Drops
1.2.3 Gels
1.2.4 Ointments
1.3 Medications for Dry Eye Syndrome Segment by Application
1.3.1 Global Medications for Dry Eye Syndrome Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Medications for Dry Eye Syndrome Market Size Estimates and Forecasts
1.4.1 Global Medications for Dry Eye Syndrome Revenue 2018-2029
1.4.2 Global Medications for Dry Eye Syndrome Sales 2018-2029
1.4.3 Global Medications for Dry Eye Syndrome Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medications for Dry Eye Syndrome Market Competition by Manufacturers
2.1 Global Medications for Dry Eye Syndrome Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medications for Dry Eye Syndrome Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medications for Dry Eye Syndrome Average Price by Manufacturers (2018-2023)
2.4 Global Medications for Dry Eye Syndrome Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medications for Dry Eye Syndrome, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medications for Dry Eye Syndrome, Product Type & Application
2.7 Medications for Dry Eye Syndrome Market Competitive Situation and Trends
2.7.1 Medications for Dry Eye Syndrome Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medications for Dry Eye Syndrome Players Market Share by Revenue
2.7.3 Global Medications for Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medications for Dry Eye Syndrome Retrospective Market Scenario by Region
3.1 Global Medications for Dry Eye Syndrome Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medications for Dry Eye Syndrome Global Medications for Dry Eye Syndrome Sales by Region: 2018-2029
3.2.1 Global Medications for Dry Eye Syndrome Sales by Region: 2018-2023
3.2.2 Global Medications for Dry Eye Syndrome Sales by Region: 2024-2029
3.3 Global Medications for Dry Eye Syndrome Global Medications for Dry Eye Syndrome Revenue by Region: 2018-2029
3.3.1 Global Medications for Dry Eye Syndrome Revenue by Region: 2018-2023
3.3.2 Global Medications for Dry Eye Syndrome Revenue by Region: 2024-2029
3.4 North America Medications for Dry Eye Syndrome Market Facts & Figures by Country
3.4.1 North America Medications for Dry Eye Syndrome Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medications for Dry Eye Syndrome Sales by Country (2018-2029)
3.4.3 North America Medications for Dry Eye Syndrome Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medications for Dry Eye Syndrome Market Facts & Figures by Country
3.5.1 Europe Medications for Dry Eye Syndrome Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medications for Dry Eye Syndrome Sales by Country (2018-2029)
3.5.3 Europe Medications for Dry Eye Syndrome Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medications for Dry Eye Syndrome Market Facts & Figures by Country
3.6.1 Asia Pacific Medications for Dry Eye Syndrome Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medications for Dry Eye Syndrome Sales by Country (2018-2029)
3.6.3 Asia Pacific Medications for Dry Eye Syndrome Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medications for Dry Eye Syndrome Market Facts & Figures by Country
3.7.1 Latin America Medications for Dry Eye Syndrome Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medications for Dry Eye Syndrome Sales by Country (2018-2029)
3.7.3 Latin America Medications for Dry Eye Syndrome Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medications for Dry Eye Syndrome Market Facts & Figures by Country
3.8.1 Middle East and Africa Medications for Dry Eye Syndrome Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medications for Dry Eye Syndrome Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medications for Dry Eye Syndrome Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medications for Dry Eye Syndrome Sales by Type (2018-2029)
4.1.1 Global Medications for Dry Eye Syndrome Sales by Type (2018-2023)
4.1.2 Global Medications for Dry Eye Syndrome Sales by Type (2024-2029)
4.1.3 Global Medications for Dry Eye Syndrome Sales Market Share by Type (2018-2029)
4.2 Global Medications for Dry Eye Syndrome Revenue by Type (2018-2029)
4.2.1 Global Medications for Dry Eye Syndrome Revenue by Type (2018-2023)
4.2.2 Global Medications for Dry Eye Syndrome Revenue by Type (2024-2029)
4.2.3 Global Medications for Dry Eye Syndrome Revenue Market Share by Type (2018-2029)
4.3 Global Medications for Dry Eye Syndrome Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medications for Dry Eye Syndrome Sales by Application (2018-2029)
5.1.1 Global Medications for Dry Eye Syndrome Sales by Application (2018-2023)
5.1.2 Global Medications for Dry Eye Syndrome Sales by Application (2024-2029)
5.1.3 Global Medications for Dry Eye Syndrome Sales Market Share by Application (2018-2029)
5.2 Global Medications for Dry Eye Syndrome Revenue by Application (2018-2029)
5.2.1 Global Medications for Dry Eye Syndrome Revenue by Application (2018-2023)
5.2.2 Global Medications for Dry Eye Syndrome Revenue by Application (2024-2029)
5.2.3 Global Medications for Dry Eye Syndrome Revenue Market Share by Application (2018-2029)
5.3 Global Medications for Dry Eye Syndrome Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bausch & Lomb
6.1.1 Bausch & Lomb Corporation Information
6.1.2 Bausch & Lomb Description and Business Overview
6.1.3 Bausch & Lomb Medications for Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bausch & Lomb Medications for Dry Eye Syndrome Product Portfolio
6.1.5 Bausch & Lomb Recent Developments/Updates
6.2 URSAPHARM Arzneimittel GmbH
6.2.1 URSAPHARM Arzneimittel GmbH Corporation Information
6.2.2 URSAPHARM Arzneimittel GmbH Description and Business Overview
6.2.3 URSAPHARM Arzneimittel GmbH Medications for Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
6.2.4 URSAPHARM Arzneimittel GmbH Medications for Dry Eye Syndrome Product Portfolio
6.2.5 URSAPHARM Arzneimittel GmbH Recent Developments/Updates
6.3 Alcon Inc.
6.3.1 Alcon Inc. Corporation Information
6.3.2 Alcon Inc. Description and Business Overview
6.3.3 Alcon Inc. Medications for Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Alcon Inc. Medications for Dry Eye Syndrome Product Portfolio
6.3.5 Alcon Inc. Recent Developments/Updates
6.4 Bayer Inc.
6.4.1 Bayer Inc. Corporation Information
6.4.2 Bayer Inc. Description and Business Overview
6.4.3 Bayer Inc. Medications for Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer Inc. Medications for Dry Eye Syndrome Product Portfolio
6.4.5 Bayer Inc. Recent Developments/Updates
6.5 Allergan
6.5.1 Allergan Corporation Information
6.5.2 Allergan Description and Business Overview
6.5.3 Allergan Medications for Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Allergan Medications for Dry Eye Syndrome Product Portfolio
6.5.5 Allergan Recent Developments/Updates
6.6 SCOPE
6.6.1 SCOPE Corporation Information
6.6.2 SCOPE Description and Business Overview
6.6.3 SCOPE Medications for Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
6.6.4 SCOPE Medications for Dry Eye Syndrome Product Portfolio
6.6.5 SCOPE Recent Developments/Updates
6.7 Johnson & Johnson Consumer Inc
6.6.1 Johnson & Johnson Consumer Inc Corporation Information
6.6.2 Johnson & Johnson Consumer Inc Description and Business Overview
6.6.3 Johnson & Johnson Consumer Inc Medications for Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson & Johnson Consumer Inc Medications for Dry Eye Syndrome Product Portfolio
6.7.5 Johnson & Johnson Consumer Inc Recent Developments/Updates
6.8 Novartis Pharmaceuticals Corporation
6.8.1 Novartis Pharmaceuticals Corporation Corporation Information
6.8.2 Novartis Pharmaceuticals Corporation Description and Business Overview
6.8.3 Novartis Pharmaceuticals Corporation Medications for Dry Eye Syndrome Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Novartis Pharmaceuticals Corporation Medications for Dry Eye Syndrome Product Portfolio
6.8.5 Novartis Pharmaceuticals Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medications for Dry Eye Syndrome Industry Chain Analysis
7.2 Medications for Dry Eye Syndrome Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medications for Dry Eye Syndrome Production Mode & Process
7.4 Medications for Dry Eye Syndrome Sales and Marketing
7.4.1 Medications for Dry Eye Syndrome Sales Channels
7.4.2 Medications for Dry Eye Syndrome Distributors
7.5 Medications for Dry Eye Syndrome Customers
8 Medications for Dry Eye Syndrome Market Dynamics
8.1 Medications for Dry Eye Syndrome Industry Trends
8.2 Medications for Dry Eye Syndrome Market Drivers
8.3 Medications for Dry Eye Syndrome Market Challenges
8.4 Medications for Dry Eye Syndrome Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
